Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia

Thrombosis and Haemostasis

Volumn 103, Issue 6, 2010, Pages 1272-1274

  Rolf, Nina ^a,b   Suttorp, Meinolf ^b   Budde, Ulrich ^c   Siegert, Gabriele ^d   Knoefler, Ralf ^b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Medilys Laboratory   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; VON WILLEBRAND FACTOR; CD34 ANTIGEN;

ADOLESCENT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HEMARTHROSIS; HUMAN; LETTER; MENORRHAGIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA; VON WILLEBRAND DISEASE; BIOSYNTHESIS; BLEEDING; BLOOD CELL COUNT; COMPLICATION; JOINT; METABOLISM; PARTIAL THROMBOPLASTIN TIME; PATHOLOGY; PROTEIN MULTIMERIZATION; PROTHROMBIN TIME; REMISSION; SPLENOMEGALY; THROMBOCYTE; THROMBOCYTHEMIA, ESSENTIAL; VON WILLEBRAND DISEASES;

ADOLESCENT; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD PLATELETS; FEMALE; HEMORRHAGE; HUMANS; HYDROXYUREA; JOINTS; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PROTEIN MULTIMERIZATION; PROTHROMBIN TIME; REMISSION INDUCTION; SPLENOMEGALY; THROMBOCYTHEMIA, ESSENTIAL; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 77953168823     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-12-0871     Document Type: Letter

References (23)

1. El-Moneim AA, Kratz CP, Böll S, et al. Essential versus reactive thrombocythaemia in children: retrospective analyses of 12 cases. Pediatr Blood Cancer 2007; 49: 52-55.
2. Hasle H. Incidence of essential thrombocythaemia in children. Br J Haematol 2000; 110: 751.
3. Putti MC, Giona F, Consario C, et al. Retrospective evaluation of 90 children with essential thrombocythaemia: the AIEOP Experience. Blood 2008, 112: 248.
4. Dror Y, Zipursky A, Blanchette VS. Essential thrombocythemia in children. J Pediatr Hematol Oncol 1999; 21: 356-363.
5. Randi ML, Putti MC, Fabris F, et al. Features of essential thrombocythaemia in childhood: a study of five children. Br J Haematol 2000; 108: 86-89.
6. Scherer S, Ferrari R, Rister M. Treatment of essential thrombocythaemia in childhood. Pediatr Hematol Oncol 2003; 20: 361-365.
7. Randi ML, Putti MC, Scapin M, et al. Pediatric patients with essential thrombocythaemia are mostly polyclonal and V617FJAK2 negative. Blood 2006; 108: 3600-3602.
8. Budde U, Schneppenheim R, Plendl H, et al. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990; 63: 312-315.
9. Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005; 129: 165-177.
10. Barbui T, Barosi G, Grossi A, et al. Practice guidelines for the therapy of essential thrombocythaemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89: 215-232.
11. Budde U, Schneppenheim R. Von Willebrand factor and von Willebrand disease. Rev Clin Exp Hematol 2001; 5: 335-368.
12. Franchini M, Lippi G. Acquired von Willebrand syndrome: an update. Am J Hematol 2007; 82: 368-375.
13. Budde U, Scharf RE, Franke P, et al. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993; 82: 1749-1757.
14. Shim K, Anderson PJ, Tuley EA, et al. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood 2008, 111: 651-657.
15. Budde U, Dent JA, Berkowitz SD, et al. Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome. Blood 1986; 68: 1213-1217.
16. Michiels JJ, Budde U, van der Planken M, et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol 2001; 14: 401-436.
17. Michiels JJ, Berneman Z, Schroyens W, et al. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and haemorrhagic manifestations in essential thrombocythaemia and polycythemia vera. Semin Thromb Hemost 2006; 32: 589-604.
18. Krebs M, Meyer B, Quehenberger P, et al. Massive postoperative intramuscular bleeding in acquired von Willebrand's disease. Ann Hematol 2002; 81: 394-396.
19. Schneppenheim R. The evolving classification of von Willebrand syndrome. Blood Coagul Fibrinolysis 2005; 16 (Suppl 1): S3-S10.
20. Federici AB, Rand JH, Bucciarelli P, et al. Acquired von Willebrand syndrome: Data from an International Registry. Thromb Haemost 2000; 84: 345-349.
21. Budde U, van Genderen PJ. Acquired von Willebrand syndrome in patients with high platelet counts. Semin Thromb Hemost 1997; 23: 425-431.
22. Michiels JJ. Acquired von Willebrand syndrome due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythaemia. Clin Appl Thromb Hemost 1999; 5: 147-151.
23. Federici AB, Budde U, Rand JH. Acquired von Willebrand syndrome 2004: International Registry - diagnosis and management from online to bedside. Hämostaseologie 2004; 24: 50-55.